These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 27575559)
1. Cathepsin L is crucial for the development of early experimental diabetic nephropathy. Garsen M; Rops AL; Dijkman H; Willemsen B; van Kuppevelt TH; Russel FG; Rabelink TJ; Berden JH; Reinheckel T; van der Vlag J Kidney Int; 2016 Nov; 90(5):1012-1022. PubMed ID: 27575559 [TBL] [Abstract][Full Text] [Related]
2. Impaired Podocyte Autophagy Exacerbates Proteinuria in Diabetic Nephropathy. Tagawa A; Yasuda M; Kume S; Yamahara K; Nakazawa J; Chin-Kanasaki M; Araki H; Araki S; Koya D; Asanuma K; Kim EH; Haneda M; Kajiwara N; Hayashi K; Ohashi H; Ugi S; Maegawa H; Uzu T Diabetes; 2016 Mar; 65(3):755-67. PubMed ID: 26384385 [TBL] [Abstract][Full Text] [Related]
3. Hyperoside pre-treatment prevents glomerular basement membrane damage in diabetic nephropathy by inhibiting podocyte heparanase expression. An X; Zhang L; Yuan Y; Wang B; Yao Q; Li L; Zhang J; He M; Zhang J Sci Rep; 2017 Jul; 7(1):6413. PubMed ID: 28743882 [TBL] [Abstract][Full Text] [Related]
4. Role of heparanase-driven inflammatory cascade in pathogenesis of diabetic nephropathy. Goldberg R; Rubinstein AM; Gil N; Hermano E; Li JP; van der Vlag J; Atzmon R; Meirovitz A; Elkin M Diabetes; 2014 Dec; 63(12):4302-13. PubMed ID: 25008182 [TBL] [Abstract][Full Text] [Related]
5. Heparanase Is Essential for the Development of Acute Experimental Glomerulonephritis. Garsen M; Benner M; Dijkman HB; van Kuppevelt TH; Li JP; Rabelink TJ; Vlodavsky I; Berden JH; Rops AL; Elkin M; van der Vlag J Am J Pathol; 2016 Apr; 186(4):805-15. PubMed ID: 26873445 [TBL] [Abstract][Full Text] [Related]
6. Endothelin-1 Induces Proteinuria by Heparanase-Mediated Disruption of the Glomerular Glycocalyx. Garsen M; Lenoir O; Rops AL; Dijkman HB; Willemsen B; van Kuppevelt TH; Rabelink TJ; Berden JH; Tharaux PL; van der Vlag J J Am Soc Nephrol; 2016 Dec; 27(12):3545-3551. PubMed ID: 27026367 [TBL] [Abstract][Full Text] [Related]
7. Hyperoside reduces albuminuria in diabetic nephropathy at the early stage through ameliorating renal damage and podocyte injury. Zhang J; Fu H; Xu Y; Niu Y; An X J Nat Med; 2016 Oct; 70(4):740-8. PubMed ID: 27255369 [TBL] [Abstract][Full Text] [Related]
8. Heparanase is essential for the development of diabetic nephropathy in mice. Gil N; Goldberg R; Neuman T; Garsen M; Zcharia E; Rubinstein AM; van Kuppevelt T; Meirovitz A; Pisano C; Li JP; van der Vlag J; Vlodavsky I; Elkin M Diabetes; 2012 Jan; 61(1):208-16. PubMed ID: 22106160 [TBL] [Abstract][Full Text] [Related]
9. Low-Dose IL-17 Therapy Prevents and Reverses Diabetic Nephropathy, Metabolic Syndrome, and Associated Organ Fibrosis. Mohamed R; Jayakumar C; Chen F; Fulton D; Stepp D; Gansevoort RT; Ramesh G J Am Soc Nephrol; 2016 Mar; 27(3):745-65. PubMed ID: 26334030 [TBL] [Abstract][Full Text] [Related]
10. Involvement of human heparanase in the pathogenesis of diabetic nephropathy. Katz A; Van-Dijk DJ; Aingorn H; Erman A; Davies M; Darmon D; Hurvitz H; Vlodavsky I Isr Med Assoc J; 2002 Nov; 4(11):996-1002. PubMed ID: 12489489 [TBL] [Abstract][Full Text] [Related]
11. p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency. Wolf G; Schanze A; Stahl RA; Shankland SJ; Amann K Kidney Int; 2005 Oct; 68(4):1583-9. PubMed ID: 16164635 [TBL] [Abstract][Full Text] [Related]
12. Loganin attenuates diabetic nephropathy in C57BL/6J mice with diabetes induced by streptozotocin and fed with diets containing high level of advanced glycation end products. Liu K; Xu H; Lv G; Liu B; Lee MK; Lu C; Lv X; Wu Y Life Sci; 2015 Feb; 123():78-85. PubMed ID: 25623853 [TBL] [Abstract][Full Text] [Related]
13. Coexpression of heparanase activity, cathepsin L, tissue factor, tissue factor pathway inhibitor, and MMP-9 in proliferative diabetic retinopathy. Abu El-Asrar AM; Siddiquei MM; Nawaz MI; De Hertogh G; Mohammad G; Alam K; Mousa A; Opdenakker G Mol Vis; 2016; 22():424-35. PubMed ID: 27168718 [TBL] [Abstract][Full Text] [Related]
14. Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy. Zhang M; Liu M; Xiong M; Gong J; Tan X J Ethnopharmacol; 2012 May; 141(1):111-8. PubMed ID: 22353431 [TBL] [Abstract][Full Text] [Related]
15. Systemic Monocyte Chemotactic Protein-1 Inhibition Modifies Renal Macrophages and Restores Glomerular Endothelial Glycocalyx and Barrier Function in Diabetic Nephropathy. Boels MGS; Koudijs A; Avramut MC; Sol WMPJ; Wang G; van Oeveren-Rietdijk AM; van Zonneveld AJ; de Boer HC; van der Vlag J; van Kooten C; Eulberg D; van den Berg BM; IJpelaar DHT; Rabelink TJ Am J Pathol; 2017 Nov; 187(11):2430-2440. PubMed ID: 28837800 [TBL] [Abstract][Full Text] [Related]
16. Heparanase induces a differential loss of heparan sulphate domains in overt diabetic nephropathy. Wijnhoven TJ; van den Hoven MJ; Ding H; van Kuppevelt TH; van der Vlag J; Berden JH; Prinz RA; Lewis EJ; Schwartz M; Xu X Diabetologia; 2008 Feb; 51(2):372-82. PubMed ID: 18058084 [TBL] [Abstract][Full Text] [Related]